abstract |
The present invention provides a nucleic acid having β2GPI expression-suppressing activity, a pharmaceutical composition containing the nucleic acid, and an autoimmune disease such as APS and SLE containing the nucleic acid, and a prophylactic or therapeutic agent for thrombosis in hemodialysis. |